Head-to-Head

Damora Therapeutics, Inc. Ordinary Shares vs. Johnson & Johnson

DMRA

Damora Therapeutics, Inc. Ordinary Shares

$24.53 -0.89%

VS JNJ

Johnson & Johnson

$267.89 +0.26%

Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

DMRAJNJ
Market Cap $1.51 billion $643.92 billion
Revenue (TTM) — $97.93 billion
Net Income (TTM) — $21.04 billion

JNJ leads on 1 of 1 size & scale factors.

Valuation

DMRAJNJ
P/E Ratio — 31.08
Price / Book — 7.58
Price / Sales — 6.58

DMRA and JNJ split the valuation factors evenly.

Profitability

DMRAJNJ
Net Margin — 21.48%
Return on Equity — 24.76%

DMRA and JNJ split the profitability factors evenly.

Dividend

DMRAJNJ
Dividend Yield — 2.00%
Payout Ratio — 62.18

DMRA and JNJ split the dividend factors evenly.

Risk & Sentiment

DMRAJNJ
Short Interest 0.69% 0.67%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: DMRA overview, DMRA financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.